Fenwick & West represented Akido Labs in the transaction. Akido Labs (“Akido”), an AI and healthcare delivery company, announced raising $60 million in Series B funding...
Akido Labs’ $60 Million Series B Funding Round
ACELYRIN’s Merger with Alumis
Fenwick & West and Paul Hastings advised ACELYRIN, INC. on the transaction, and Cooley advised Alumis Inc. ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company...